5-Amino-1MQ

5-Amino-1MQ, also known as 5-amino-1-methylquinolinium, is a metabolic research compound that functions as a nicotinamide N-methyltransferase (NNMT) inhibitor. This compound has garnered significant interest in metabolic research due to its unique mechanism of action and potential applications in energy metabolism studies. The primary mechanism of 5-Amino-1MQ involves the inhibition of the NNMT enzyme, which plays a crucial role in regulating energy metabolism. By blocking NNMT activity, this compound increases the availability of nicotinamide adenine dinucleotide (NAD+), a vital coenzyme essential for cellular energy production. This enhancement of NAD+ levels supports improved mitochondrial function and energy expenditure in research models. Studies indicate that 5-Amino-1MQ may influence fat metabolism by altering the expression of genes involved in adipogenesis. Research has demonstrated several primary effects in laboratory settings, including increased NAD+ levels that enhance cellular energy metabolism, promotion of lipolysis through modulation of adipogenesis, improved mitochondrial function, and potential reduction in markers of metabolic syndrome. The current evidence base for 5-Amino-1MQ is classified as grade C, with most research derived from animal studies and in vitro experiments. These investigations suggest potential benefits in metabolic regulation and lipolysis mechanisms. However, it is important to note that there are currently no published human clinical trials specifically investigating this NNMT inhibitor compound, highlighting the need for further research to establish comprehensive safety profiles and confirm the effects observed in preliminary studies.